Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 01:30:02 16/07/2024 am IST			5-day change	1st Jan Change
544.7 ^USD	-0.62%		+1.56%	+2.62%

11/07	Thermo Fisher Scientific Keeps Quarterly Cash Dividend at $0.39 Per Share, Payable Oct. 15 to Holders as of Sept. 13	MT
11/07	Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2024	CI

Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2024

July 12, 2024 at 02:00 am IST

Thermo Fisher Scientific Inc. announced that its Board of Directors authorized a quarterly cash dividend of $0.39 per common share, payable on October 15, 2024, to shareholders of record as of September 13, 2024.

Latest news about Thermo Fisher Scientific

Thermo Fisher Scientific Keeps Quarterly Cash Dividend at $0.39 Per Share, Payable Oct. 15 to Holders as of Sept. 13	12/07	MT
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on October 15, 2024	12/07	CI
Thermo Fisher Scientific to Work With National Cancer Institute to Advance Research on New Treatments	11/07	MT
Thermo Fisher Scientific to Help Advance Myeloid Cancer Clinical Research and Treatment Utilizing Next Generation Sequencing Technology	11/07	CI
Thermo Fisher Scientific Completes Acquisition of Olink	10/07	MT
Thermo Fisher Scientific Inc. completed the acquisition of Olink Holding AB from Summa Equity AB and others.	10/07	CI
Thermo Fisher Scientific Opens Its First Electron Microscopy Demo Center in Taiwan	09/07	CI
Olink Holding Receives UK Approval for Thermo Fisher's $26 per Share Tender Offer	08/07	MT
UK Competition Watchdog Clears Thermo Fisher Scientific's Purchase of Sweden's Olink	08/07	MT
UK's competition regulator clears $3.1 billion Thermo Fisher Scientific-Olink deal	08/07	RE
Evercore ISI Cuts Price Target on Thermo Fisher Scientific to $600 From $615, Maintains Outperform Rating	02/07	MT
Verici Dx hails milestone payment in deal with Thermo Fisher	01/07	AN
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell Top 200 Growth Index	01/07	CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000 Growth Index	01/07	CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 3000E Growth Index	01/07	CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth Index	01/07	CI
Thermo Fisher Scientific Inc.(NYSE:TMO) dropped from Russell 1000 Growth-Defensive Index	01/07	CI
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Kentucky	28/06	CI
Barclays Adjusts Price Target on Thermo Fisher Scientific to $600 From $615	27/06	MT
Labguru Announces New Distribution Partnership with Thermo Fisher Scientific of its Electronic Lab Notebook Module to Help Streamline Life Sciences Research	26/06	CI
Thermo Fisher Scientific Introduces the Only Fully Automated Plasmid Purification System to Help Accelerate Discovery and Development of Therapies	25/06	CI
RBC Trims Price Target on Thermo Fisher Scientific to $660 From $662, Keeps Outperform Rating	24/06	MT
Thermo Fisher Scientific Inc. Expands Clinical Research Laboratory in Wisconsin	18/06	CI
Thermo Fisher Scientific Inc., National University Hospital, Singapore and Mirxes Collaborates to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore	18/06	CI
Verici Dx plc Announces Successful Transfer of Urine Samples to Thermo Fisher Scientific	18/06	CI

Chart Thermo Fisher Scientific

Duration

Period

More charts

Company Profile

Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

24/07/2024 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Thermo Fisher Scientific

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

544.7 USD

Average target price

628.2 USD

Spread / Average Target

+15.33%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+2.62%	208B
DANAHER CORPORATION	+6.44%	182B
INTUITIVE SURGICAL, INC.	+29.61%	155B
BOSTON SCIENTIFIC CORPORATION	+34.96%	115B
SIEMENS HEALTHINEERS AG	+3.84%	66.52B
EDWARDS LIFESCIENCES CORPORATION	+17.38%	53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.26B
AGILENT TECHNOLOGIES, INC.	-5.77%	38.22B
GE HEALTHCARE TECHNOLOGIES INC.	+3.71%	36.6B
RESMED, INC.	+19.35%	30.16B

Other Advanced Medical Equipment & Technology